Shenzhen Qianhai Taikang International Hospital

Medical Excellence

Shenzhen Qianhai Taikang International Hospital is the flagship medical institution of the Qianhai Health Innovation Zone. It operates through a strategic partnership between Taikang Insurance Group (one of China's largest health insurers) and Cedars-Sinai Medical Center (Los Angeles, USA), aiming to deliver Cedars-Sinai-level clinical standards at Chinese pricing. As a designated GBA Drug & Device Measure hospital, Taikang Qianhai can administer medications approved in Hong Kong that are not yet registered in mainland China — giving international patients access to Western pharmaceutical standards without Hong Kong's premium pricing. The hospital specializes in oncology, cardiovascular medicine, neurosciences, and regenerative medicine. It features newly built facilities designed to international hospital standards, with private rooms, advanced imaging, and integrated rehabilitation. Hong Kong-style clinical governance and audit systems ensure international-class quality assurance.